BSE filing, NSE: CMMHOSP. Summary written from the filing by ALFA Finder's alert engine.
Chennai Meenakshi Multispeciality Hospital Ltd: key numbers
- Share price
- ₹34.00
- Market cap
- ₹25.39 Cr
- Revenue (annual)
- ₹37.04 Cr
- Net profit (annual)
- ₹-1.12 Cr
- P/E (TTM)
- -62.0×Sector 51.1×
- Promoter holding
- 57.10%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chennai Meenakshi Multispeciality Hospital Ltd
All →Chennai Meenakshi Multispeciality Hospital Other Announcement
Quarterly shareholding pattern for the period ended September 30, 2026, filed in compliance with SEBI Regulation 31(1)(b).
Chennai Meenakshi Multispeciality Hospital Board Meeting Outcome
Chennai Meenakshi Multispeciality Hospital Limited has reconstituted its Audit Committee and Stakeholders Relationship Committee following the recent cessation of certain directors from the Board.
Chennai Meenakshi Multispeciality Hospital Annual General Meeting
Chennai Meenakshi Multispeciality Hospital conducted its 36th Annual General Meeting on September 30, 2026, transacting ordinary and special business items via remote e-voting and AGM voting.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital has announced book closure dates from September 24 to September 30, 2026, for its 36th Annual General Meeting.
Chennai Meenakshi Multispeciality Hospital Annual Report
Chennai Meenakshi Multispeciality Hospital filed its 36th Annual Report and AGM Notice for the financial year 2025-26. The AGM is scheduled for September 30, 2026.
Chennai Meenakshi Multispeciality Hospital Annual General Meeting
Chennai Meenakshi Multispeciality Hospital Ltd has scheduled its 36th Annual General Meeting on September 30, 2026, to be conducted via video conferencing.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.